Fabian Trillsch

ORCID: 0000-0002-1860-4350 · 13 papers in corpus
observational 2026
Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08331-4

OBJECTIVE: The study aimed to evaluate the long-term outcomes of surgical management in patients with peritoneal endometriosis, focusing on postoperative pain trajectories, re-operation rates, fertility outcomes, and the potential influence…

other 2024
Translational oncology ·doi:10.1016/j.tranon.2024.102116

OBJECTIVES: The chemokine CCL22 is recognized for recruiting immunosuppressive regulatory T-cells (Treg) that contribute to disease progression in various tumor entities helping them to evade the host immune response. Our study aims to iden…

other 2023
MMW Fortschritte der Medizin ·doi:10.1007/s15006-023-2298-0
other 2022
Scientific reports ·doi:10.1038/s41598-022-05785-9

In recurrent epithelial ovarian cancer (EOC) most patients develop platinum-resistance. On molecular level the NRF2 pathway, a cellular defense mechanism against reactive oxygen species, is induced. In this study, we investigate AKR1C1/2, t…

review 2022
MMW Fortschritte der Medizin ·doi:10.1007/s15006-022-2175-2
observational 2022
Archives of gynecology and obstetrics ·doi:10.1007/s00404-022-06730-x

PURPOSE: Endometriosis is known to be an underestimated disease. Lately the awareness of the disease seems to have improved. Aim of this analysis is to provide an overview of the development of treatment of patients diagnosed with endometri…

observational 2022
·doi:10.21203/rs.3.rs-1784980/v1

Abstract PurposeEndometriosis is known to be an underestimated disease. Lately the awareness of the disease seems to have improved. Aim of this analysis is to provide an overview of the development of treatment of patients diagnosed with e…

review 2021
Cancers ·doi:10.3390/cancers13133349

Gynaecological malignancies represent a heterogeneous group of neoplasms with vastly different aetiology, risk factors, molecular drivers, and disease outcomes. From HPV-driven cervical cancer where early screening and molecular diagnostics…

case-report 2021
Journal of ovarian research ·doi:10.1186/s13048-021-00839-4

BACKGROUND: For young borderline ovarian tumor (BOT) patients, preservation of the uterus was incorporated as an accepted option into treatment guidelines. For the endometrioid subtype (eBOT) however, adequate histological evaluation is cha…

observational 2020
Journal of cancer research and clinical oncology ·doi:10.1007/s00432-020-03241-7

PURPOSE: Thyroid hormone receptors (THR) have manifold functions and are involved in the carcinogenesis of several tumor types. Within this study, we aimed to investigate the expression pattern (nuclear versus cytoplasmic) of the THR alpha …

other 2020
Histochemistry and cell biology ·doi:10.1007/s00418-020-01873-x

Several risk factors like obesity and hyperlipidemia were described for endometrial cancer. Here, the nuclear NAD-dependent histone-deacetylase Sirtuin1 (SIRT1) seems to be important. SIRT1 is also involved in cell regulatory mechanisms and…

observational 2017
Oncology letters ·doi:10.3892/ol.2017.6592

The present study aimed to identify differences in protein expression in cases of endometrioid endometrial cancer (EEC) with and without coexisting adenomyosis uteri (AM), and to evaluate the histopathological and prognostic distinctions. T…

observational 2013
Journal of ovarian research ·doi:10.1186/1757-2215-6-48

BACKGROUND: Surgery is the cornerstone for clinical management of patients with borderline ovarian tumors (BOT). As these patients have an excellent overall prognosis, perioperative morbidity is the critical point for decision making when t…